| EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection P Lampertico, K Agarwal, T Berg, M Buti, HLA Janssen, ... Journal of hepatology 67 (2), 370-398, 2017 | 9391* | 2017 |
| Treatment of HCV infection by targeting microRNA HLA Janssen, HW Reesink, EJ Lawitz, S Zeuzem, M Rodriguez-Torres, ... New England Journal of Medicine 368 (18), 1685-1694, 2013 | 2598 | 2013 |
| Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis AJ Van Der Meer, BJ Veldt, JJ Feld, H Wedemeyer, JF Dufour, F Lammert, ... Jama 308 (24), 2584-2593, 2012 | 1902 | 2012 |
| Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial HLA Janssen, M van Zonneveld, H Senturk, S Zeuzem, US Akarca, ... The Lancet 365 (9454), 123-129, 2005 | 1585 | 2005 |
| Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis BJ Veldt, EJ Heathcote, H Wedemeyer, J Reichen, WP Hofmann, ... Annals of internal medicine 147 (10), 677-684, 2007 | 873 | 2007 |
| Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection JN Stoop, RG van der Molen, CC Baan, LJW van der Laan, EJ Kuipers, ... Hepatology 41 (4), 771-778, 2005 | 835 | 2005 |
| Hepatitis B virus infection MF Yuen, DS Chen, GM Dusheiko, HLA Janssen, DTY Lau, SA Locarnini, ... Nature reviews Disease primers 4 (1), 1-20, 2018 | 783 | 2018 |
| EASL Clinical Practice Guidelines: Vascular diseases of the liver European Association For The Study Of The Liver Journal of hepatology 64 (1), 179-202, 2016 | 757 | 2016 |
| Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity T Lisman, TN Bongers, J Adelmeijer, HLA Janssen, MPM de Maat, ... Hepatology 44 (1), 53-61, 2006 | 715 | 2006 |
| Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow‐up study A Plessier, S Darwish‐Murad, M Hernandez‐Guerra, Y Consigny, ... Hepatology 51 (1), 210-218, 2010 | 666 | 2010 |
| Etiology, management, and outcome of the Budd-Chiari syndrome SD Murad, A Plessier, M Hernandez-Guerra, F Fabris, CE Eapen, ... Annals of internal medicine 151 (3), 167-175, 2009 | 642 | 2009 |
| Budd–Chiari syndrome: a review by an expert panel HLA Janssen, JC Garcia-Pagan, E Elias, G Mentha, A Hadengue, ... Journal of hepatology 38 (3), 364-371, 2003 | 637 | 2003 |
| Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma JC Chambers, W Zhang, J Sehmi, X Li, MN Wass, P Van der Harst, ... Nature genetics 43 (11), 1131-1138, 2011 | 630 | 2011 |
| Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver FE De Jongh, HLA Janssen, A Robert, WCJ Hop, SW Schalm, ... Gastroenterology 103 (5), 1630-1635, 1992 | 613 | 1992 |
| Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy GV Papatheodoridis, HLY Chan, BE Hansen, HLA Janssen, P Lampertico Journal of hepatology 62 (4), 956-967, 2015 | 546 | 2015 |
| Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study WJ Lammers, HR van Buuren, GM Hirschfield, HLA Janssen, P Invernizzi, ... Gastroenterology 147 (6), 1338-1349. e5, 2014 | 544 | 2014 |
| Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon α-2b EHCJ Buster, HJ Flink, Y Cakaloglu, K Simon, J Trojan, F Tabak, TMK So, ... Gastroenterology 135 (2), 459-467, 2008 | 528 | 2008 |
| Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind … M Buti, E Gane, WK Seto, HLY Chan, WL Chuang, T Stepanova, AJ Hui, ... The lancet Gastroenterology & hepatology 1 (3), 196-206, 2016 | 522 | 2016 |
| Factors that predict response of patients with hepatitis B e antigen–Positive chronic hepatitis B to peginterferon-alfa EHCJ Buster, BE Hansen, GKK Lau, T Piratvisuth, S Zeuzem, ... Gastroenterology 137 (6), 2002-2009, 2009 | 509 | 2009 |
| Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a … HLA Janssen, JR Meinardi, FP Vleggaar, SHM van Uum, EB Haagsma, ... Blood, The Journal of the American Society of Hematology 96 (7), 2364-2368, 2000 | 508 | 2000 |
